vs

Side-by-side financial comparison of AURORA CANNABIS INC (ACB) and COHEN & STEERS, INC. (CNS). Click either name above to swap in a different company.

COHEN & STEERS, INC. is the larger business by last-quarter revenue ($143.8M vs $81.6M, roughly 1.8× AURORA CANNABIS INC). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs -756.4%, a 780.6% gap on every dollar of revenue. AURORA CANNABIS INC produced more free cash flow last quarter ($-8.6M vs $-126.4M).

Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. ...

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

ACB vs CNS — Head-to-Head

Bigger by revenue
CNS
CNS
1.8× larger
CNS
$143.8M
$81.6M
ACB
Higher net margin
CNS
CNS
780.6% more per $
CNS
24.3%
-756.4%
ACB
More free cash flow
ACB
ACB
$117.8M more FCF
ACB
$-8.6M
$-126.4M
CNS

Income Statement — Q1 FY2024 vs Q4 FY2025

Metric
ACB
ACB
CNS
CNS
Revenue
$81.6M
$143.8M
Net Profit
$-617.0M
$34.9M
Gross Margin
8.7%
Operating Margin
-73.7%
28.0%
Net Margin
-756.4%
24.3%
Revenue YoY
2.9%
Net Profit YoY
-23.9%
EPS (diluted)
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACB
ACB
CNS
CNS
Q4 25
$143.8M
Q3 25
$141.7M
Q2 25
$136.1M
Q1 25
$134.5M
Q4 24
$139.8M
Q3 24
$133.2M
Q2 24
$121.7M
Q1 24
$122.7M
Net Profit
ACB
ACB
CNS
CNS
Q4 25
$34.9M
Q3 25
$41.7M
Q2 25
$36.8M
Q1 25
$39.8M
Q4 24
$45.8M
Q3 24
$39.7M
Q2 24
$31.8M
Q1 24
$34.0M
Operating Margin
ACB
ACB
CNS
CNS
Q4 25
28.0%
Q3 25
34.5%
Q2 25
31.8%
Q1 25
33.6%
Q4 24
35.3%
Q3 24
33.7%
Q2 24
31.5%
Q1 24
32.8%
Net Margin
ACB
ACB
CNS
CNS
Q4 25
24.3%
Q3 25
29.4%
Q2 25
27.1%
Q1 25
29.6%
Q4 24
32.8%
Q3 24
29.8%
Q2 24
26.1%
Q1 24
27.7%
EPS (diluted)
ACB
ACB
CNS
CNS
Q4 25
$0.67
Q3 25
$0.81
Q2 25
$0.72
Q1 25
$0.77
Q4 24
$0.89
Q3 24
$0.77
Q2 24
$0.63
Q1 24
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACB
ACB
CNS
CNS
Cash + ST InvestmentsLiquidity on hand
$145.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$562.0M
Total Assets
$876.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACB
ACB
CNS
CNS
Q4 25
$145.5M
Q3 25
$98.1M
Q2 25
$95.4M
Q1 25
$65.2M
Q4 24
$183.0M
Q3 24
$106.5M
Q2 24
$122.0M
Q1 24
$99.5M
Stockholders' Equity
ACB
ACB
CNS
CNS
Q4 25
$562.0M
Q3 25
$550.3M
Q2 25
$528.5M
Q1 25
$507.7M
Q4 24
$511.7M
Q3 24
$491.0M
Q2 24
$463.2M
Q1 24
$378.9M
Total Assets
ACB
ACB
CNS
CNS
Q4 25
$876.7M
Q3 25
$801.6M
Q2 25
$751.0M
Q1 25
$834.9M
Q4 24
$812.4M
Q3 24
$727.8M
Q2 24
$784.1M
Q1 24
$680.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACB
ACB
CNS
CNS
Operating Cash FlowLast quarter
$-4.3M
$-120.4M
Free Cash FlowOCF − Capex
$-8.6M
$-126.4M
FCF MarginFCF / Revenue
-10.6%
-87.9%
Capex IntensityCapex / Revenue
5.3%
4.2%
Cash ConversionOCF / Net Profit
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACB
ACB
CNS
CNS
Q4 25
$-120.4M
Q3 25
$55.1M
Q2 25
$-67.6M
Q1 25
$-108.9M
Q4 24
$96.7M
Q3 24
$25.6M
Q2 24
$31.4M
Q1 24
$4.9M
Free Cash Flow
ACB
ACB
CNS
CNS
Q4 25
$-126.4M
Q3 25
$52.6M
Q2 25
$-69.8M
Q1 25
$-110.0M
Q4 24
$85.0M
Q3 24
$24.2M
Q2 24
$27.1M
Q1 24
$537.0K
FCF Margin
ACB
ACB
CNS
CNS
Q4 25
-87.9%
Q3 25
37.1%
Q2 25
-51.3%
Q1 25
-81.8%
Q4 24
60.8%
Q3 24
18.2%
Q2 24
22.3%
Q1 24
0.4%
Capex Intensity
ACB
ACB
CNS
CNS
Q4 25
4.2%
Q3 25
1.8%
Q2 25
1.6%
Q1 25
0.8%
Q4 24
8.3%
Q3 24
1.1%
Q2 24
3.5%
Q1 24
3.5%
Cash Conversion
ACB
ACB
CNS
CNS
Q4 25
-3.45×
Q3 25
1.32×
Q2 25
-1.84×
Q1 25
-2.74×
Q4 24
2.11×
Q3 24
0.65×
Q2 24
0.99×
Q1 24
0.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons